Diabetics use glucose monitors. Should non-diabetics use them too?
Not everyone in the health field is so bullish on the prospects of CGMs for everyone, and question whether digging in too ...
全球首个365天连续血糖监测传感器获得FDA批准上市
近期，Senseonics（NYSE：SENS）及其商业伙伴Ascensia Diabetes Care宣布，其创新的Eversense ...
Eversense 365 CGM系统推出，实现全年糖尿病监测
马里兰州杰曼镇 - 医疗技术公司Senseonics Holdings, Inc. (NYSE American: SENS)与医疗服务提供商Mercy合作，宣布首次商业应用Eversense® 365连续血糖监测(CGM)系统。该系统是目前唯一能为1型和2型糖尿病成年患者提供全年血糖监测的系统。 Eversense 365是一种可植入的CGM系统，上个月获得美国食品和药物管理局批准，在最初14天 ...
Trinity Biotech推进下一代血糖监测仪研发
都柏林 - 专注于诊断系统和糖尿病管理的生物技术公司Trinity Biotech plc (NASDAQ:TRIB)今天宣布，其创新型连续血糖监测(CGM)技术在欧洲成功完成了关键的预关键临床试验。这标志着继2024年1月收购Waveform Technologies资产后的一个重要里程碑。 此次试验评估了改进后的CGM技术的分析性能，这是Trinity Biotech研发努力的一部分，旨在提高 ...
drugdeliverybusiness13 天
Senseonics, Ascensia launch Eversense 365 year-long CGM in the U.S.
Ascensia Diabetes Care announced today that it launched the Eversense 365 CGM system from Senseonics (NYSE:SENS) ...
Down More Than 50% From Its High, Is DexCom Stock a Buy?
A top healthcare stock to own over the years has been DexCom (DXCM 1.18%). The company makes continuous glucose monitors ...
Managed Healthcare Executive11 天
Diabetes Quality Measures Have Challenges But Also Successes
Sean M. Oser, M.D., M.P.H., an associate professor in the Department of Family Medicine at the University of Colorado School ...
clinicaladvisor.com3 天
Cases of Adverse Mental Health Outcomes Developing With Continuous Glucose Monitoring
The study author endorses preassessment and providing psychoeducation or combining CGM initiation with therapy, mindfulness, ...
Medscape4 天
CGM With Geriatric Care Simplifies T1D Management in Seniors
Continuous glucose monitoring enhanced by geriatric care principles reduced the duration of hypoglycemia without worsening ...
大众网12 天
第6艘！青船公司6000TEU集装箱船“CMA CGM DOLOMITES”轮成功命名
近日，青船公司与比利时CMB公司合作建造的6000TEU集装箱船6号船“CMA CGM DOLOMITES”轮举行盛大命名仪式，这也是该型船建造的最后一艘。截至今年7月，前5艘6000TEU集装箱船均已顺利交付。
证券之星 on MSN4 天
三诺生物：10月10日接受机构调研，投资者参与
证券之星消息，2024年10月10日三诺生物（300298）发布公告称公司于2024年10月10日接受机构调研。 具体内容如下： 问：三诺生物在2024年的研发投入增加，这对公司的长期发展有何影响？
2 Beaten-Down Growth Stocks You Might Regret Not Buying
But even if we aren't in a bear market, buying shares of beaten-down stocks that have what it takes to recover is also an ...